ArticleAnnals of hematology2024
Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia.
Daniel Zechariah Paul Jebanesan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it